ArisGlobal to Discuss AI Enabled Data Fabric and Emerging Pharmacovigilance Technologies at World Drug Safety

Oct 20, 2021

The life sciences R&D technology leader will lead keynote sessions on both days of World Drug Safety Boston

Miami, FL October 20, 2021 – ArisGlobal, the leading provider of software that automates core product development functions for over 300 global life sciences companies, will be featured as safety thought leaders at the largest global pharmacovigilance conference, World Drug Safety Congress Americas on October 21-22, 2021.

The Day 1 conference agenda will close with a joint keynote session between two central Safety leaders at ArisGlobal, Beena Wood, VP, Safety Product Management, and Manny Belabe, Associate VP, Safety Business Unit, as they discuss the digital transformation opportunities in today’s pharmacovigilance environment and how a strong and strategic data fabric is a core realization of successful automation.

“It is an honor to participate in World Drug Safety Congress Americas and to showcase how AI & machine learning are continuing to advance and innovate pharmacovigilance,” shares Belabe. I am incredibly passionate about these topics, and I look forward to sharing emerging technology, insights, and opportunities, such as our LifeSphere suite, to this audience of safety professionals.”

Day 2 will kick off with a keynote panel between Belabe and Rahul Khajuria, Senior Director, Global Head Of Drug Safety Systems and Analytics at United Therapeutics, where they will discuss emerging technologies that are transforming pharmacovigilance, such as artificial intelligence, machine learning, and blockchain. Challenges such as data silos within pharmacovigilance teams will also be an area of focus. The conversation will be moderated by Michael Glaser,Safety Innovation Technology Director, GSK.

These innovative discussions come on the heels of previous virtual sessions delivered by both Wood and Belabe on the benefits of end-to-end AI enabled data fabric at ArisGlobal’s signature conference, Breakthrough2021, along with recent safety automation perspectives between Belabe and EVERSANA.

LATEST NEWS

Additional Information

Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global

Contact

Erika Thomas
ArisGlobal
+305-726-6601 | ethomas@arisglobal.com

About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global

Contact

Erika Thomas
ArisGlobal
+305-726-6601 | ethomas@arisglobal.com